Clinical Trial

A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA

Name: A Cohort Study of the Efficacy and Safety of Biologics in Patients With ABPA — clinical trial record (NCT07362693)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of biological agents in patients with allergic bronchopulmonary aspergillosis.

Protocol Amendment History 1 change

critical Recruitment opened 2026-04-18

Trial Details

NCT Number	NCT07362693
Lead Sponsor	Qianfoshan Hospital
Conditions	ABPA, Biologics, Allergic Bronchopulmonary Aspergillosis (ABPA), Cohort Study, Allergic Bronchopulmonary Aspergillosis, Efficacy and Safety
Enrollment	50 participants
Start Date	2025-01-31
Primary Completion	2028-12-31 (estimated)
Study Completion	2028-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-17